Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Photodiagnosis and Photodynamic Therapy|January 12, 2016
The clinical trial on the safety and effectiveness of the photodynamic diagnosis of non-muscle-invasive bladder cancer using fluorescent light-guided cystoscopy after oral administration of 5-aminolevulinic acid (5-ALA)Keiji Inoue, Hideyasu Matsuyama, Kiyohide Fujimoto, et al.
World Journal of Urology|July 3, 2015
Validation of major prognostic models for metastatic urothelial carcinoma using a multi-institutional cohort of the real worldSatoru Taguchi, Tohru Nakagawa, Yukari Uemura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|April 24, 2015
Pretreatment neutrophil-to-lymphocyte ratio as an independent predictor of survival in patients with metastatic urothelial carcinoma: A multi-institutional studySatoru Taguchi, Tohru Nakagawa, Akihiko Matsumoto, et al.
World Journal of Urology|May 16, 2016
Prognostic significance of serum neuron-specific enolase in small cell carcinoma of the urinary bladderAkihiro Naito, Satoru Taguchi, Tohru Nakagawa, et al.
World Journal of Urology|November 30, 2017
Preoperative chronic kidney disease is predictive of oncological outcome of radical cystectomy for bladder cancerAkihiko Matsumoto, Tohru Nakagawa, Atsushi Kanatani, et al.
Annals of Surgical Oncology|July 9, 2017
Oncologic Outcome of Metastasectomy for Urothelial Carcinoma: Who Is the Best Candidate?Tohru Nakagawa, Satoru Taguchi, Atsushi Kanatani, et al.
Urologic Oncology|January 24, 2017
Nomogram for predicting survival of postcystectomy recurrent urothelial carcinoma of the bladderTohru Nakagawa, Satoru Taguchi, Yukari Uemura, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|August 23, 2022
Improved survival in real-world patients with advanced urothelial carcinoma: A multicenter propensity score-matched cohort study comparing a period before the introduction of pembrolizumab (2003-2011) and a more recent period (2016-2020)Satoru Taguchi, Taketo Kawai, Tohru Nakagawa, et al.
Pageof 2